PuSH - Publication Server of Helmholtz Zentrum München

42 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Nono Nankam, P.A. & Blüher, M.: Retinol-binding protein 4 in obesity and metabolic dysfunctions. Mol. Cell. Endocrinol. 531:111312 (2021)
Tokarz, J. ; Lintelmann, J. ; Möller, G. & Adamski, J.: Substrate multispecificity among 20 beta-hydroxysteroid dehydrogenase type 2 members. Mol. Cell. Endocrinol. 510:110822 (2020)
Amri, E.Z.* & Scheideler, M.: Small non coding RNAs in adipocyte biology and obesity. Mol. Cell. Endocrinol. 456, 87-94 (2017)
Tews, D.* et al.: Teneurin-2 (TENM2) deficiency induces UCP1 expression in differentiating human fat cells. Mol. Cell. Endocrinol. 443, 106-113 (2017)
Finan, B. ; Clemmensen, C. & Müller, T.D.: Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists. Mol. Cell. Endocrinol. 418, 42-54 (2015)
Lockie, S.H.* ; Stefanidis, A.* ; Tschöp, M.H. & Oldfield, B.J.*: Combination cannabinoid and opioid receptor antagonists improves metabolic outcomes in obese mice. Mol. Cell. Endocrinol. 417, 10-19 (2015)
Vukicevic, V.* et al.: Adrenomedullary progenitor cells: Isolation and characterization of a multi-potent progenitor cell population. Mol. Cell. Endocrinol. 408, 178-184 (2015)
Wiedemann, T. & Pellegata, N.S.: Animal models of multiple endocrine neoplasia. Mol. Cell. Endocrinol. 421, 49-59 (2015)
Raitoharju, E.* et al.: Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome : The Cardiovascular Risk in Young Finns study. Mol. Cell. Endocrinol. 389, 41-49 (2014)
Lim, C.T.* et al.: Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism. Mol. Cell. Endocrinol. 365, 303-308 (2013)
Stevanovic, D.* et al.: Ghrelin-induced food intake and adiposity depend on central mTORC1/S6K1 signaling. Mol. Cell. Endocrinol. 381, 280-290 (2013)
Graf, C.* et al.: Corticotropin-releasing hormone regulates common target genes with divergent functions in corticotrope and neuronal cells. Mol. Cell. Endocrinol. 362, 29-38 (2012)
Tokarz, J. et al.: Discovery of a novel enzyme mediating glucocorticoid catabolism in fish: 20beta-hydroxysteroid dehydrogenase type 2. Mol. Cell. Endocrinol. 349, 202-213 (2012)
van Buerck, L.* et al.: Enhanced oxidative stress and endocrine pancreas alterations are linked to a novel glucokinase missense mutation in ENU-derived Munich GckD217V mutants. Mol. Cell. Endocrinol. 362, 139-148 (2012)
Zitzelsberger, H. ; Thomas, G.* & Unger, K.*: Chromosomal aberrations in thyroid follicular-cell neoplasia: In the search of novel oncogenes and tumour suppressor genes. Mol. Cell. Endocrinol. 321, 57-66 (2010)
Adamski, J.: Pre-receptor steroid metabolism as target for pharmacological treatment. Mol. Cell. Endocrinol. 301, 1-1 (2009)
Brozic, P.* et al.: Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. Mol. Cell. Endocrinol. 301, 229-234 (2009)
Hult, M.* et al.: Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms. Mol. Cell. Endocrinol. 301, (Sp. Iss. SI), 109-116 (2009)
Keller, B. ; Meier, M. & Adamski, J.: Comparison of predicted and experimental subcellular localization of two putative rat steroid dehydrogenases from the short-chain dehydrogenase/reductase protein superfamily. Mol. Cell. Endocrinol. 301, 43-46 (2009)
Mindnich, R.* & Adamski, J.: Zebrafish 17β-hydroxysteroid dehydrogenases: An evolutionary perspective. Mol. Cell. Endocrinol. 301, (Sp. Iss. SI), 20-26 (2009)